Table 1:
Total | InstaCare | Connect Care | KidsCare | |
---|---|---|---|---|
N = 1,163,849 | N = 1,043,040 | N = 37,453 | N = 83,356 | |
Encounter Level Patient Demographics | ||||
White | 83.6% (n=973,289) | 84.3% (n=878,835) | 83.4% (n=31,221) | 75.9% (n=63,233) |
Female | 56.7% (n=659,663) | 57% (n=594,868) | 64.2% (n=24,030) | 48.9% (n=40,765) |
Patient age, median | 30 (IQI 15–48)* | 32 (IQI 19–50) | 33 (IQI 19–43) | 6 (IQI 2–11) |
Physician Provider | 90% (n=104,451)* | 92.5% (n=961,057) | 0.5% (n=205) | 100% (n=83,189) |
Advanced Practice Provider | 10% (n=115,542)* | 7.5% (n=78,294) | 99.5% (n=37,248) | 0% (n=0) |
Encounter Level Clinical Categories | ||||
Respiratory | 41.8% (n=486,061) | 40.8% (n=426,070) | 47% (n=17,621) | 50.8% (n=42,370) |
Skin | 13.7% (n=159,009) | 13.8% (n=143,831) | 12.4% (n=4,635) | 12.6% (n=10,543) |
GU | 8.1% (n=93,855) | 8.4% (n=87,149) | 12.1% (n=4,541) | 2.6% (n=2,165) |
GI | 6.3% (n=73,823) | 6.4% (n=66,665) | 5.7% (n=2,132) | 6% (n=5,026) |
Other | 25.3% (n=294,261) | 25.8% (n=269,250) | 18.3% (n=6,862) | 21.8% (n=18,149) |
Unclassified | 4.9% (n=56,840) | 4.8% (n=50,075) | 4.4% (n=1,662) | 6.1% (n=5,103) |
Tier 1 | 11.9% (n=135,113) | 12.3% (n=125,018) | 8.7% (n=3,229) | 8.6% (n=6,866) |
Tier 2 | 30.1% (n=341,050) | 29.7% (n=302,337) | 33.1% (n=12,271) | 33% (n=26,442) |
Tier 3 | 55.6% (n=630,846) | 55.6% (n=565,610) | 54.7% (n=20,291) | 56.1% (n=44,945) |
Encounter Level Antibiotic Prescribing Rate | ||||
Total antibiotic prescribing Rate | 34.1% (n=396,825) | 34.9% (n=364,097) | 32.6% (n=12,208) | 24.6% (n=20,520) |
4 encounters were missing patient age data and 3,856 encounters were missing provider specialty data
Tier 1: Antibiotics are almost always indicated (e.g., pneumonia)
Tier 2: Antibiotics may be indicated (e.g., sinusitis)
Tier 3: Antibiotics not indicated (e.g., bronchitis)
IQI = Interquartile Interval